Cancer Genetics
Volume 204, Issue 12 , Pages 646-653 , December 2011

Two novel unbalanced whole arm translocations are frequently detected in cervical squamous cell carcinoma

  • Claudia Backsch

      Affiliations

    • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany
    • Corresponding Author InformationCorresponding author.
    • ,
  • Birgit Pauly

      Affiliations

    • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany
    • Institut für Bakterielle Infektionen und Zoonosen, Friedrich-Loeffler-Institut, Jena, Germany
    • ,
  • Melanie Liesenfeld

      Affiliations

    • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany
    • ,
  • Cornelia Scheungraber

      Affiliations

    • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany
    • ,
  • Mieczyslaw Gajda

      Affiliations

    • Institut für Pathologie, Universitätsklinikum Jena, Jena, Germany
    • ,
  • Kristin Mrasek

      Affiliations

    • Institut für Humangenetik, Universitätsklinikum Jena, Jena, Germany
    • ,
  • Thomas Liehr

      Affiliations

    • Institut für Humangenetik, Universitätsklinikum Jena, Jena, Germany
    • ,
  • Andreas Clad

      Affiliations

    • Klinik für Gynäkologie und Gynäkologische Onkologie, Universitätsklinikum Freiburg, Freiburg, Germany
    • ,
  • Evelin Schrock

      Affiliations

    • Institut für Klinische Genetik, Technische Universität, Dresden, Germany
    • ,
  • Ingo B. Runnebaum

      Affiliations

    • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany
    • ,
  • Matthias Dürst

      Affiliations

    • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany

Received 20 November 2010 ,Revised 14 October 2011 ,Accepted 16 October 2011.

References 

  1. Atkin N, Baker MC, Fox MF. Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet Cytogenet. 1990;44:229–241
  2. Backsch C, Rudolph B, Kühne-Heid R, et al. A region on human chromosome 4 (q35.1-->qter) induces senescence in cell hybrids and is involved in cervical carcinogenesis. Genes Chromosomes Cancer. 2005;43:260–272
  3. Hampton G, Larson A, Baergen R, et al. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA. 1996;93:6704–6709
  4. Heselmeyer K, Macville M, Schröck E, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer. 1997;19:233–240
  5. Heselmeyer K, Schröck E, du Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA. 1996;93:479–484
  6. Kallioniemi A, Kallioniemi O, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818–821
  7. Solinas-Toldo S, Dürst M, Lichter P. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. Proc Natl Acad Sci USA. 1997;94:3854–3859
  8. Macville M, Schröck E, Padilla-Nash H, et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 1999;59:141–150
  9. Schröck E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science. 1996;273:494–497
  10. Darroudi F, Bergs J, Bezrookove V, et al. PCC and COBRA-FISH a new tool to characterize primary cervical carcinomas: to assess hall-marks and stage specificity. Cancer Lett. 2010;287:67–74
  11. Albertson D, Collins C, McCormick F, et al. Chromosome aberrations in solid tumors. Nat Genet. 2003;34:369–376
  12. Hopman A, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol. 2004;202:23–33
  13. De Braekeleer M, Sreekantaiah C, Haas O. Herpes simplex virus and human papillomavirus sites correlate with chromosomal breakpoints in human cervical carcinoma. Cancer Genet Cytogenet. 1992;59:135–137
  14. Dürst M, Dzarlieva-Petrusevska R, Boukamp P, et al. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1987;1:251–256
  15. Dürst M, Bosch F, Glitz D, et al. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol. 1991;65:796–804
  16. Rohlfs M, Winkenbach S, Meyer S, et al. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virol. 1991;183:331–342
  17. Poignèe M, Backsch C, Beer K, et al. Evidence for a putative senscence gene locus within the chromosomal region 10p14-15. Cancer Res. 2001;61:7118–7121
  18. Barclay L. Tissue culture techniques and chromosome preparation. In:  Verma RS,  Babu R editor. Human chromosomes: principles and techniques. New York: McGraw-Hill, Inc; 1995;p. 6–63
  19. Schröck E, Veldman T, Padilla-Nash H, et al. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet. 1997;101:255–262
  20. Speel E, Ramaekers F, Hopman A. Sensitive multicolor fluorescence in situ hybridization using catalyzed reporter deposition (CARD) amplification. J Histochem Cytochem. 1997;45:1439–1446
  21. Baretton G, Müller M, Wirtz A, et al. Numerical chromosome aberrations in abortion tissue. Comparison of conventional cytogenetics and interphase cytogenetics in paraffin sections and nuclear suspensions. Pathologe. 1998;19:120–128
  22. Stoehr R, Wissmann C, Suzuki H, et al. Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest. 2004;84:465–478
  23. Harris C, Lu X, Narayan G, et al. Comprehensive molecular cytogenetic haracterization of cervical cancer cell lines. Genes Chromosomes Cancer. 2003;36:233–241
  24. Cottage A, Dowen S, Roberts I, et al. Early genetic events in HPV immortalised keratinocytes. Genes Chromosomes Cancer. 2001;30:72–79
  25. Jin C, Jin Y, Wennerberg J, et al. Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet. 2002;132:85–96
  26. Hermsen M, Snijders A, Guervós M, et al. Centromeric chromosomal translocations show tissue-specific differences between squamous cell carcinomas and adenocarcinomas. Oncogene. 2005;24:1571–1579
  27. Bardi G, Sukhikh T, Pandis N, et al. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer. 1995;12:97–109
  28. Debiec-Rychter M, Alwasiak J, Liberski P, et al. Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases. Cancer Genet Cytogenet. 1995;85:61–67
  29. Douglass E, Valentine M, Green A, et al. t(11;22) and other chromosomal rearrangements in Ewing’s sarcoma. J Natl Cancer Inst. 1993;77:1211–1215
  30. Jin Y, Martins C, Salemark L, et al. Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet. 2001;131:109–119
  31. Nilsson M, Meza-Zepeda L, Mertens F, et al. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer. 2004;109:363–369
  32. Becher R, Gibas Z, Karakousis C, et al. Nonrandom chromosome changes in malignant melanoma. Cancer Res. 1983;43:5010–5016
  33. Mandahl N, Gustafson P, Mertens F, et al. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer. 2002;33:188–200
  34. Martínez-Ramírez A, Urioste M, Alvarez S, et al. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping. Cancer Genet Cytogenet. 2004;153:39–47
  35. Johansson B, Arheden K, Höglund M, et al. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies. Genes Chromosomes Cancer. 1995;14:56–62
  36. Hermsen M, Joenje H, Arwert F, et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer. 1996;15:1–9
  37. Martins C, Jin Y, Jin C, et al. Fluorescent in situ hybridisation (FISH) characterisation of pericentromeric breakpoints on chromosome 5 in head and neck squamous cell carcinomas. Eur J Cancer. 1999;35:498–501
  38. Hansen R, Wijmenga C, Luo P, et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA. 1999;96:14412–14417
  39. Okano M, Bell D, Haber D, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257
  40. Wilting S, Snijders P, Meijer G, et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol. 2006;209:220–230
  41. Ehrlich M, Jiang G, Fiala E, et al. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene. 2006;21:6694–6702
  42. Mills K, Ferguson D, Alt F. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev. 2003;194:77–95
  43. Agarwal S, Tafel A, Kanaar R. DNA double-strand break repair and chromosome translocations. DNA Repair. 2006;5:1075–1081
  44. Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251–262
  45. Küppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001;20:5580–5594
  46. Felix C, Kolaris C, Osheroff N. Topoisomerase II and the etiology of chromosomal translocations. DNA Repair. 2006;5:1093–1108
  47. Bakshi R, Galande S, Muniyappa K. Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase. Crit Rev Biochem Mol Biol. 2001;36:1–37
  48. Floridia G, Zatterale A, Zuffardi O, et al. Mapping of a human centromere onto the DNA by topoisomerase II cleavage. EMBO Rep. 2000;6:489–493
  49. Steenbergen R, de Wilde J, Wilting S, et al. HPV-mediated transformation of the anogenital tract. J Clin Virol. 2005;32S:S25–S33
  50. Heselmeyer-Haddad K, Sommerfeld K, White N, et al. Genomic amplification of the human telomerase gene (TERC) in Pap smears predicts the development of cervical cancer. Am J Pathol. 2005;166:1229–1238
  51. Caraway N, Khanna A, Dawlett M, et al. Gain of the 3q26 region in cervicovaginal liquid-based Pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol. 2008;110:37–42
  52. Andersson S, Sowjanya P, Wangsa D, et al. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol. 2009;175:1831–1847
  53. Sui W, Ou M, Dai Y, et al. Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma. Int J Gynecol Cancer. 2009;19:1303–1306
  54. Jiang J, Wei L, Li Y, et al. Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China. J Mol Diagn. 2010;12:808–817

PII: S2210-7762(11)00302-4

doi: 10.1016/j.cancergen.2011.10.009

Cancer Genetics
Volume 204, Issue 12 , Pages 646-653 , December 2011

Article Tools

* Image Usage & Resolution